Watch the video from 50 sec onwards to learn hear about Gain Therapeutics
Gain Therapeutics was mentioned on Fox Business News as a company to watch for its pioneering use of applying AI to the development of Parkinson’s disease therapies. The company’s clinical-stage lead program has a best-in-class preclinical data package, which includes promising preclinical studies indicating disease reversal in mice, highlighting its potential for groundbreaking innovation. The program, which attracted grant funding support from the Michael J. Fox Foundation, is currently in clinical trials, provides the hope of future Parkinson’s treatments that go beyond symptom management.
